The pharmaceutical industry faces substantial challenges in developing novel therapies. Timelines are often prolonged, costs are skyrocketing and success rates remain inadequate. Integrated discovery solutions, however, offer a promising pathway to overcome these hurdles. By linking various stages of the drug development pipeline, from target ident